Logo image of ALBT

AVALON GLOBOCARE CORP (ALBT) Stock Fundamental Analysis

USA - NASDAQ:ALBT - US05344R3021 - Common Stock

2.46 USD
+0.06 (+2.5%)
Last: 9/26/2025, 8:00:00 PM
2.46 USD
0 (0%)
After Hours: 9/26/2025, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALBT. ALBT was compared to 64 industry peers in the Real Estate Management & Development industry. ALBT may be in some trouble as it scores bad on both profitability and health. ALBT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALBT had negative earnings in the past year.
In the past year ALBT has reported a negative cash flow from operations.
ALBT had negative earnings in each of the past 5 years.
In the past 5 years ALBT always reported negative operating cash flow.
ALBT Yearly Net Income VS EBIT VS OCF VS FCFALBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

ALBT has a Return On Assets of -252.65%. This is amonst the worse of the industry: ALBT underperforms 89.06% of its industry peers.
Industry RankSector Rank
ROA -252.65%
ROE N/A
ROIC N/A
ROA(3y)-59.75%
ROA(5y)-78.06%
ROE(3y)-148.3%
ROE(5y)-209.56%
ROIC(3y)N/A
ROIC(5y)N/A
ALBT Yearly ROA, ROE, ROICALBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500

1.3 Margins

The Gross Margin of ALBT (24.63%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALBT has declined.
The Profit Margin and Operating Margin are not available for ALBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.46%
GM growth 5Y-6.82%
ALBT Yearly Profit, Operating, Gross MarginsALBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

1

2. Health

2.1 Basic Checks

ALBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBT has more shares outstanding
ALBT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALBT has been reduced compared to a year ago.
ALBT Yearly Shares OutstandingALBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALBT Yearly Total Debt VS Total AssetsALBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -23.02, we must say that ALBT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -23.02, ALBT is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.02
ROIC/WACCN/A
WACC11.75%
ALBT Yearly LT Debt VS Equity VS FCFALBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

ALBT has a Current Ratio of 0.06. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALBT (0.06) is worse than 89.06% of its industry peers.
ALBT has a Quick Ratio of 0.06. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.06, ALBT is doing worse than 90.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
ALBT Yearly Current Assets VS Current LiabilitesALBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.66% over the past year.
The Revenue has been growing slightly by 7.53% in the past year.
ALBT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.97% yearly.
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118.35%
Revenue 1Y (TTM)7.53%
Revenue growth 3Y-1.38%
Revenue growth 5Y-2.97%
Sales Q2Q%6.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBT Yearly Revenue VS EstimatesALBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBT Price Earnings VS Forward Price EarningsALBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALBT Per share dataALBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVALON GLOBOCARE CORP

NASDAQ:ALBT (9/26/2025, 8:00:00 PM)

After market: 2.46 0 (0%)

2.46

+0.06 (+2.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-18 2025-08-18
Earnings (Next)11-10 2025-11-10
Inst Owners0.58%
Inst Owner Change16.81%
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap9.45M
AnalystsN/A
Price TargetN/A
Short Float %3.67%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-11.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.56
OCFYN/A
SpS0.36
BVpS-1.85
TBVpS-1.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -252.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.63%
FCFM N/A
ROA(3y)-59.75%
ROA(5y)-78.06%
ROE(3y)-148.3%
ROE(5y)-209.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.46%
GM growth 5Y-6.82%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -23.02
F-Score4
WACC11.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.53%
Revenue growth 3Y-1.38%
Revenue growth 5Y-2.97%
Sales Q2Q%6.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.12%
OCF growth 3YN/A
OCF growth 5YN/A